ZNF385B is characteristically expressed in germinal center B cells and involved in B-cell apoptosis

European Journal of Immunology

Volumn 42, Issue 12, 2012, Pages 3405-3415

  Iijima, Kazutoshi ^a   Yamada, Hiroyuki ^a   Miharu, Masashi ^a   Imadome, Ken Ichi ^a   Miyagawa, Yoshitaka ^a,b   Akimoto, Shingo ^a   Kobayashi, Kenichiro ^a   Okita, Hajime ^a   Nakazawa, Atsuko ^c   Fujiwara, Shigeyoshi ^a   Fujimoto, Junichiro ^d   Kiyokawa, Nobutaka ^a  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c Department of Pathology   (Japan)

^d NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

Apoptosis; B cell development; Cell survival; DNA repair mechanisms; Lymphoid organs

Indexed keywords

BCR ABL PROTEIN; CASPASE; CD20 ANTIGEN; PROTEIN P53; TETRACYCLINE; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; ZINC FINGER PROTEIN 385B;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL LINE; CONTROLLED STUDY; ECTOPIC TISSUE; ENZYME ACTIVATION; GENE DELETION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ANTIGENS, CD20; APOPTOSIS; B-LYMPHOCYTES; CELL LINE; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION; GERMINAL CENTER; HUMANS; MALE; TRANSCRIPTIONAL ACTIVATION; TUMOR SUPPRESSOR PROTEIN P53; ZINC FINGERS;

EID: 84871299930     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201242530     Document Type: Article

References (33)

1. Gatto, D. and Brink, R., The germinal center reaction. J. Allergy Clin. Immunol. 2010. 126: 898-907.
2. Goodnow, C. C., Vinuesa, C. G., Randall, K. L., Mackay, F. and Brink, R., Control systems and decision making for antibody production. Nat. Immunol. 2010. 11: 681-688.
3. Levine, M. H., Haberman, A. M., Sant'Angelo, D. B., Hannum, L. G., Cancro, M. P., Janeway, C. A. Jr. and Shlomchik, M. J., A B-cell receptor-specific selection step governs immature to mature B cell differentiation. Proc. Natl. Acad. Sci. USA 2000. 97: 2743-2748.
4. Hanley-Hyde, J. M. and Lynch, R. G., The physiology of B cells as studied with tumor models. Annu. Rev. Immunol. 1986. 4: 621-649.
5. Gregory, C. D., Tursz, T., Edwards, C. F., Tetaud, C., Talbot, M., Caillou, B., Rickinson, A. B. et al., Identification of a subset of normal B cells with a Burkitt's lymphoma (BL)-like phenotype. J. Immunol. 1987. 139: 313-318.
6. Kiyokawa, N., Kokai, Y., Ishimoto, K., Fujita, H., Fujimoto, J. and Hata, J. I., Characterization of the common acute lymphoblastic leukaemia antigen (CD10) as an activation molecule on mature human B cells. Clin. Exp. Immunol. 1990. 79: 322-327.
7. Mangeney, M., Lingwood, C. A., Taga, S., Caillou, B., Tursz, T. and Wiels, J., Apoptosis induced in Burkitt's lymphoma cells via Gb3/CD77, a glycolipid antigen. Cancer Res. 1993. 53: 5314-5319.
8. Bellan, C., Lazzi, S., Hummel, M., Palummo, N., de Santi, M., Amato, T., Nyagol, J. et al., Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas. Blood 2005. 106: 1031-1036.
9. Sharma, S., Dimasi, D, Higginson, K. and Della, N. G., RZF, a zinc-finger protein in the photoreceptors of human retina. Gene 2004. 342: 219-229.
10. Das, S., Raj, L., Zhao, B., Kimura, Y., Bernstein, A., Aaronson, S. A. and Lee, S. W., Hzf determines cell survival upon genotoxic stress by modulating p53 transactivation. Cell 2007. 130: 624-637.
11. Caron, G., Le Gallou, S., Lamy, T., Tarte, K. and Fest, T., CXCR4 expression functionally discriminates centroblasts versus centrocytes within human germinal center B cells. J. Immunol. 2009. 182: 7595-7602.
12. Attardi, L. D., Reczek, E. E., Cosmas, C., Demicco, E. G., McCurrach, M. E., Lowe, S. W. and Jacks, T., PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family. Genes Dev. 2000. 14: 704-718.
13. 2 phase checkpoint induced by DNA damage. Mol. Cell. Biol. 2006. 26: 502-512.
14. Nakamura, H., Kawagishi, H., Watanabe, A., Sugimoto, K., Maruyama, M. and Sugimoto, M., Cooperative role of the RNA-binding proteins Hzf and HuR in p53 activation. Mol. Cell. Biol. 2011. 31: 1997-2009.
15. Phan, R. T. and Dalla-Favera, R., The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells. Nature 2004. 432: 635-639.
16. Margalit, O., Amram, H., Amariglio, N., Simon, A. J., Shaklai, S., Granot, G., Minsky, N. et al., BCL6 is regulated by p53 through a response element frequently disrupted in B-cell non-Hodgkin lymphoma. Blood 2006. 107: 1599-1607.
17. Boldin, M. P., Goncharov, T. M., Goltsev, Y. V. and Wallach, D., Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell 1996. 85: 803-815.
18. Davies, L., Gray, D., Spiller, D., White, M. R., Damato, B., Grierson, I. and Paraoan, L., P53 apoptosis mediator PERP: localization, function and caspase activation in uveal melanoma. J. Cell. Mol. Med. 2009. 13: 1995-2007.
19. Takahashi, Y., Ohta, H. and Takemori, T., Fas is required for clonal selection in germinal centers and the subsequent establishment of the memory B cell repertoire. Immunity 2001. 14: 181-192.
20. Hao, Z., Duncan, G. S., Seagal, J., Su, Y. W., Hong, C., Haight, J., Chen, N. J. et al., Fas receptor expression in germinal-center B cells is essential for T and B lymphocyte homeostasis. Immunity 2008. 29: 615-627.
21. Farrell, P. J., Allan, G. J., Shanahan, F., Vousden, K. H. and Crook, T., p53 is frequently mutated in Burkitt's lymphoma cell lines. EMBO J. 1991. 10: 2879-2887.
22. Menezes, J., Leibold, W., Klein, G. and Clements, G., Establishment and characterization of an Epstein-Barr virus (EBC)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma. Biomedicine 1975. 22: 276-284.
23. Miki, T., Kawamata, N., Arai, A., Ohashi, K., Nakamura, Y., Kato, A., Hirosawa, S. et al., Molecular cloning of the breakpoint for 3q27 translocation in B-cell lymphomas and leukemias. Blood 1994. 83: 217-222.
24. Lenz, G., Davis, R. E., Ngo, V. N., Lam, L., George, T. C., Wright, G. W., Dave, S. S. et al., Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. Science 2008. 319: 1676-1679.
25. Sanchez-Izquierdo, D., Buchonnet, G., Siebert, R., Gascoyne, R. D., Climent, J., Karran, L., Marin, M. et al., MALT1 is deregulated by both chromosomal translocation and amplification in B-cell non-Hodgkin lymphoma. Blood 2003. 101: 4539-4546.
26. Glazer, P. M. and Summers, W. C., Oncogene expression in isogenic, EBV-positive and -negative Burkitt lymphoma cell lines. Intervirology 1985. 23: 82-89.
27. Epstein, A. L., Marder, R. J., Winter, J. N. and Fox, R. I., Two new monoclonal Abs (LN-1, LN-2) reactive in B5 formalin-fixed, paraffin-embedded tissues with follicular center and mantle zone human B lymphocytes and derived tumors. J. Immunol. 1984. 133: 1028-1036.
28. Matsuo, Y., Sugimoto, A., Harashima, A., Nishizaki, C., Ishimaru, F., Kondo, E., Katayama, Y. et al., Establishment and characterization of a novel ALL-L3 cell line (BALM-18): induction of apoptosis by anti-IgM and inhibition of apoptosis by bone marrow stroma cells. Leuk. Res. 1999. 23: 559-568.
29. Mimori, K., Kiyokawa, N., Taguchi, T., Suzuki, T., Sekino, T., Nakajima, H., Saito, M. et al., Costimulatory signals distinctively affect CD20- and B-cell-antigen-receptor-mediated apoptosis in Burkitt's lymphoma/leukemia cells. Leukemia 2003. 17: 1164-1174.
30. Fahey, J. L., Buell, D. N. and Sox, H. C., Proliferation and differentiation of lymphoid cells: studies with human lymphoid cell lines and immunoglobulin synthesis. Ann. NY. Acad. Sci. 1971. 190: 221-234.
31. Dias, J., Gumenyuk, M., Kang, H., Vodyanik, M., Yu, J., Thomson, J. A. and Slukvin, I. I., Generation of red blood cells from human induced pluripotent stem cells. Stem Cells Dev. 2011. 20: 1639-1647.
32. Matsui, J., Kiyokawa, N., Takenouchi, H., Taguchi, T., Suzuki, K., Shiozawa, Y., Saito, M. et al., Dietary bioflavonoids induce apoptosis in human leukemia cells. Leuk. Res. 2005. 29: 573-581.
33. Kiyokawa, N., Lee, E. K., Karunagaran, D., Lin, S. Y. and Hung, M. C., Mitosis-specific negative regulation of epidermal growth factor receptor, triggered by a decrease in ligand binding and dimerization, can be overcome by overexpression of receptor. J. Biol. Chem. 1997. 272: 18656-18665.